We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00403832
First Posted: November 27, 2006
Last Update Posted: July 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
St. Franziskus Hospital
  Purpose
Cataract is a common complication in uveitis patients. Cataract operations with intraocular lens implantation are difficult in these patients because of complication due to the biocompatibility of the intraocular lens. In this study, uveal and capsular biocompatibility of two widely used acrylate intraocular lenses are compared.

Condition Intervention
Uveitis Cataract Device: intraocular lenses: Two foldable, acrylic, sharp edged IOLs: AcrySof™ (AcrySof SA60AT, Alcon), and Akreos adapt™ (Bausch & Lomb)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of Two Different Acrylate Intraocular Lenses in Cataract Surgery in Patients With Non-infectious Uveitis

Resource links provided by NLM:


Further study details as provided by St. Franziskus Hospital:

Primary Outcome Measures:
  • visual acuity
  • cell deposits on anterior IOL surface
  • posterior capsular opacification

Estimated Enrollment: 60
Study Start Date: August 2005
Estimated Study Completion Date: February 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non infectious uveitis
  • no active inflammation
  • significant visual disturbance related to lens opacification

Exclusion Criteria:

  • vitreous opacification
  • ocular hypertension/glaucoma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00403832


Locations
Germany
Department of Ophthalmology at St.-Franziskus Hospital
Münster, Germany, 48145
Sponsors and Collaborators
St. Franziskus Hospital
Investigators
Principal Investigator: Arnd Heiligenhaus, Md Phd Department of Ophthalmology at St.-FranziskusHospital Münster
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00403832     History of Changes
Other Study ID Numbers: 05-2911
First Submitted: November 24, 2006
First Posted: November 27, 2006
Last Update Posted: July 28, 2010
Last Verified: August 2009

Additional relevant MeSH terms:
Cataract
Uveitis
Lens Diseases
Eye Diseases
Uveal Diseases